FDA Approves Unknown Drug — ACTAVIS LABS FL
FDA has approved a generic drug under Application #ANDA211255 manufactured by ACTAVIS LABS FL, removing any potential generic competition for the subject product. The approval is expected to establish a new pricing standard, allowing ACTAVIS LABS FL to capitalize on the market conditions for the branded drug until patents expire.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed